Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptopodin 2-like protein (SYNPO2L) is an actin-associated protein predicted to play a role in modulating actin-based cell shape and organization, particularly in muscle tissues. This protein binds to actin, is thought to be involved in sarcomere organization, stress fiber assembly, and may positively regulate Rho protein signaling. It localizes to the cytoplasm, actin cytoskeleton, Z disc, and possibly the nucleus. Mutations in SYNPO2L have been associated with familial atrial fibrillation and familial hypertrophic cardiomyopathy, suggesting a role in cardiac muscle structure or function. Currently, there are no known drugs directly targeting SYNPO2L, and it is not widely considered a classical therapeutic target such as a receptor, enzyme, or ion channel[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptopodin 2-like protein (SYNPO2L).